Zai Chang
Impact in
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- CRISPR and Genetic Engineering
- RNA modifications and cancer
- Pluripotent Stem Cells Research
- PI3K/AKT/mTOR signaling in cancer
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 5
- Metabolism, Diabetes, and Cancer 4
- CRISPR and Genetic Engineering 3
- Cancer-related gene regulation 3
- Natural product bioactivities and synthesis 2
- RNA Research and Splicing 2
- Surgery 5
- Pancreatic function and diabetes 3
- Co-authors
- Zhongzhou Yang (10 shared papers)Brian A. Hemmings (5 shared papers)Qiuting Feng (6 shared papers)Zhigang Tian (2 shared papers)Meixiang Yang (2 shared papers)Dan Li (2 shared papers)Min Yang (1 shared paper)Jing Zhang (1 shared paper)
- Journals
- Molecular and Cellular Biology (3 papers)Differentiation (1 paper)Nature Genetics (1 paper)Cytotherapy (1 paper)Phytotherapy Research (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Zai Chang
29 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 882
- Cancer Research 187
- Aging 20
- Immunology 220
- Oncology 217
Countries citing papers authored by Zai Chang
This map shows the geographic impact of Zai Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zai Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zai Chang more than expected).
Fields of papers citing papers by Zai Chang
This network shows the impact of papers produced by Zai Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zai Chang. The network helps show where Zai Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zai Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 128 | |
| 2 | 2012 | 99 | |
| 3 | 2010 | 85 | |
| 4 | 2015 | 84 | |
| 5 | 2019 | 79 | |
| 6 | 2015 | 79 | |
| 7 | 2016 | 78 | |
| 8 | 2018 | 66 | |
| 9 | 2019 | 55 | |
| 10 | 2009 | 54 | |
| 11 | 2016 | 53 | |
| 12 | 2011 | 52 | |
| 13 | 2010 | 48 | |
| 14 | 2010 | 43 | |
| 15 | 2014 | 35 | |
| 16 | 2024 | 33 | |
| 17 | 2007 | 33 | |
| 18 | 2014 | 32 | |
| 19 | Procyanidins from grape seeds protect against phorbol ester-induced oxidative cellular and genotoxic damage. | 2004 | 24 |
| 20 | 2013 | 23 |
About Zai Chang
Zai Chang is a scholar working on Molecular Biology, Surgery, Immunology, Oncology and Genetics, having authored 29 papers that have together received 1.3k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Metabolism, Diabetes, and Cancer (4 papers), CRISPR and Genetic Engineering (3 papers), Cancer-related gene regulation (3 papers), Pancreatic function and diabetes (3 papers), Mesenchymal stem cell research (2 papers), Natural product bioactivities and synthesis (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Molecular Biology (882 citations), Cancer Research (187 citations), Aging (20 citations), Immunology (220 citations) and Oncology (217 citations). Zai Chang has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Zhongzhou Yang, Brian A. Hemmings, Qiuting Feng, Zhigang Tian, Meixiang Yang, Dan Li, Min Yang, Jing Zhang, Chunhui Wang and Peng Du. Their work appears in journals such as Molecular and Cellular Biology, Differentiation, Nature Genetics, Cytotherapy and Phytotherapy Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.